These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19453875)

  • 1. The incidence of invasive breast cancer among women prescribed testosterone for low libido.
    Davis SR; Wolfe R; Farrugia H; Ferdinand A; Bell RJ
    J Sex Med; 2009 Jul; 6(7):1850-6. PubMed ID: 19453875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case series of androgen use in breast cancer survivors with sexual dysfunction.
    Krychman ML; Stelling CJ; Carter J; Hudis CA
    J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
    White WB; Grady D; Giudice LC; Berry SM; Zborowski J; Snabes MC
    Am Heart J; 2012 Jan; 163(1):27-32. PubMed ID: 22172433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.
    Dimitrakakis C; Jones RA; Liu A; Bondy CA
    Menopause; 2004; 11(5):531-5. PubMed ID: 15356405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone therapy in women: a review.
    Bolour S; Braunstein G
    Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA; Simon JA; Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
    Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
    Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and the breast.
    Shufelt CL; Braunstein GD
    Menopause Int; 2008 Sep; 14(3):117-22. PubMed ID: 18714077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and breast cancer risk.
    Kenemans P; van der Mooren MJ
    Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():46-9. PubMed ID: 22394304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
    Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
    Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone and breast cancer.
    Hall SA; Araujo AB; Kupelian V; Maserejian NN; Travison TG
    J Sex Med; 2010 Feb; 7(2 Pt 2):1035-6; author reply 1036-7. PubMed ID: 19878445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.